Microbix J (MBX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 258 | 223 | 227 | 205 | 216 |
| Accounts receivable | 1,013 | -1,385 | -15 | -2,067 | -228 |
| Other Working Capital | -335 | -1,609 | -138 | -2,621 | -208 |
| Other Operating Activity | -43 | 2,487 | 1,547 | 3,799 | 1,202 |
| Operating Cash Flow | $893 | $-284 | $1,622 | $-683 | $982 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -400 | -153 | -129 | -207 | -259 |
| Purchase Sale Intangibles | 0 | N/A | 0 | N/A | -60 |
| Other Investing Activity | 0 | 0 | 55 | 59 | 137 |
| Investing Cash Flow | $-400 | $-153 | $-74 | $-147 | $-182 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,072 | N/A | 143 | 55 | 170 |
| Debt Repayment | -91 | -1,687 | -146 | -127 | -126 |
| Common Stock Issued | N/A | N/A | -6 | 6,138 | 0 |
| Other Financing Activity | 232 | 2,633 | 941 | 725 | 284 |
| Financing Cash Flow | $1,213 | $946 | $932 | $6,792 | $328 |
| Beginning Cash Position | 10,495 | 9,986 | 7,507 | 1,545 | 417 |
| End Cash Position | 12,201 | 10,495 | 9,986 | 7,507 | 1,545 |
| Net Cash Flow | $1,706 | $509 | $2,480 | $5,961 | $1,128 |
| Free Cash Flow | |||||
| Operating Cash Flow | 893 | -284 | 1,622 | -683 | 982 |
| Capital Expenditure | -400 | -153 | -129 | -207 | -319 |
| Free Cash Flow | 493 | -437 | 1,493 | -890 | 663 |